A burgeoning biotech startup is pioneering a novel approach to drug development, aiming to replace traditional animal testing with sophisticated, lab-grown human intestinal models. Intero Biosystems, based in Denver, is developing “intestinal organoids” – miniature, lab-cultivated tissues that closely replicate the human gut’s complex structure and function. This innovation seeks to provide a more accurate […]